Stock listing
BOATS:RCUS Arcus Biosciences, Inc. Stock
US listing (BOATS) of Arcus Biosciences, Inc. · home listing NYSE:RCUS
Follow Arcus Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:RCUS
$17.85 USD -0.34 (-1.9%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:RCUS
- Day range
- $17.76 – $18.49 USDNov 2, 2026
- Volume
- 1.38M sharesNov 2, 2026
- Market cap
- $2.25B USDAt the close on Nov 2, 2026 · price × 125.8M shares outstanding
- 52-week range
- $17.43 – $31.74 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $43.68M USDMedian day 1.38M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:RCUS · Home | $17.85 USD | -0.34 (-1.9%) | 1,380,489 | $18.23 | $18.49 | $17.76 | $18.19 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NYSE:RCUS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $17.85 | -0.34 | -1.9% | $18.23 | $18.49 | $17.76 | 1,380,489 | |
| $18.19 | -0.42 | -2.3% | $18.34 | $18.90 | $17.82 | 1,935,901 | |
| $18.61 | +0.22 | +1.2% | $18.62 | $19.02 | $18.12 | 1,665,705 | |
| $18.39 | +0.25 | +1.4% | $17.85 | $18.51 | $17.77 | 2,018,619 | |
| $18.14 | +0.38 | +2.1% | $17.62 | $18.33 | $17.53 | 2,231,835 | |
| $17.76 | -0.78 | -4.2% | $18.37 | $18.62 | $17.63 | 2,696,018 | |
| $18.54 | -0.82 | -4.2% | $19.02 | $19.09 | $18.43 | 5,925,200 | |
| $19.36 | +0.26 | +1.4% | $17.43 | $19.62 | $17.43 | 8,370,900 | |
| $19.10 | -4.65 | -19.6% | $24.47 | $24.47 | $18.98 | 4,654,300 | |
| $23.75 | +1.61 | +7.3% | $21.26 | $24.70 | $20.81 | 6,242,200 | |
| $22.14 | +0.02 | +0.1% | $22.44 | $22.94 | $21.37 | 3,516,600 | |
| $22.12 | -0.70 | -3.1% | $22.79 | $22.96 | $21.60 | 1,425,500 | |
| $22.82 | +0.29 | +1.3% | $22.53 | $23.28 | $22.53 | 1,210,200 | |
| $22.53 | +0.02 | +0.1% | $22.82 | $23.47 | $22.36 | 1,212,000 | |
| $22.51 | -1.83 | -7.5% | $23.87 | $24.01 | $22.46 | 1,393,500 | |
| $24.34 | -0.07 | -0.3% | $24.42 | $24.73 | $24.12 | 1,338,000 | |
| $24.41 | +0.58 | +2.4% | $23.89 | $24.58 | $23.75 | 795,200 | |
| $23.83 | -0.69 | -2.8% | $24.29 | $24.38 | $22.80 | 1,864,700 | |
| $24.52 | +0.24 | +1.0% | $24.23 | $24.85 | $23.90 | 1,601,300 | |
| $24.28 | -0.46 | -1.9% | $24.96 | $24.96 | $23.96 | 824,800 | |
| $24.74 | +0.30 | +1.2% | $24.19 | $24.95 | $24.11 | 1,390,900 | |
| $24.44 | -0.79 | -3.1% | $25.48 | $25.58 | $24.09 | 1,041,900 | |
| $25.23 | -0.60 | -2.3% | $25.86 | $26.26 | $25.13 | 1,362,700 | |
| $25.83 | +0.18 | +0.7% | $26.18 | $26.35 | $25.56 | 1,361,900 | |
| $25.65 | +0.64 | +2.6% | $24.93 | $26.04 | $24.76 | 1,252,500 | |
| $25.01 | +0.04 | +0.2% | $24.85 | $25.51 | $24.35 | 1,249,300 | |
| $24.97 | -0.09 | -0.4% | $25.16 | $25.29 | $24.34 | 1,717,200 | |
| $25.06 | -1.33 | -5.0% | $26.20 | $26.49 | $24.42 | 2,038,400 | |
| $26.39 | -0.48 | -1.8% | $26.86 | $27.90 | $25.85 | 1,561,400 | |
| $26.87 | +0.92 | +3.5% | $26.34 | $27.11 | $26.04 | 1,385,300 | |
| $25.95 | +0.71 | +2.8% | $25.54 | $26.03 | $25.06 | 1,111,200 | |
| $25.24 | -0.30 | -1.2% | $25.74 | $25.74 | $25.02 | 2,897,100 | |
| $25.54 | +0.89 | +3.6% | $25.31 | $25.92 | $25.05 | 2,011,000 | |
| $24.65 | +0.33 | +1.4% | $24.79 | $25.28 | $24.18 | 2,295,500 | |
| $24.32 | +0.25 | +1.0% | $23.89 | $24.35 | $23.31 | 1,927,900 | |
| $24.07 | -0.52 | -2.1% | $24.59 | $24.99 | $24.02 | 1,720,800 | |
| $24.59 | -1.56 | -6.0% | $26.50 | $26.58 | $24.32 | 4,276,600 | |
| $26.15 | -2.34 | -8.2% | $28.02 | $28.46 | $25.91 | 2,391,100 | |
| $28.49 | -0.57 | -2.0% | $28.71 | $29.30 | $28.20 | 1,828,300 | |
| $29.06 | -0.60 | -2.0% | $29.21 | $29.50 | $28.79 | 1,363,500 | |
| $29.66 | -0.47 | -1.6% | $29.64 | $30.10 | $29.40 | 737,000 | |
| $30.13 | +0.28 | +0.9% | $29.92 | $30.20 | $29.20 | 681,700 | |
| $29.85 | +0.14 | +0.5% | $30.17 | $31.47 | $29.32 | 1,233,700 | |
| $29.71 | +0.43 | +1.5% | $29.18 | $29.87 | $28.68 | 1,528,500 | |
| $29.28 | +0.07 | +0.2% | $28.89 | $29.35 | $28.23 | 1,106,400 | |
| $29.21 | -1.38 | -4.5% | $30.13 | $30.44 | $29.06 | 1,086,200 | |
| $30.59 | -0.17 | -0.6% | $30.75 | $31.01 | $30.36 | 806,100 | |
| $30.76 | -0.81 | -2.6% | $31.34 | $31.46 | $30.30 | 685,600 | |
| $31.57 | +1.45 | +4.8% | $30.11 | $31.58 | $30.11 | 655,704 | |
| $30.12 | -0.22 | -0.7% | $30.27 | $30.91 | $29.38 | 1,296,258 | |
| $30.34 | +0.82 | +2.8% | $29.89 | $30.56 | $29.74 | 1,055,200 | |
| $29.52 | -0.83 | -2.7% | $29.88 | $30.39 | $28.94 | 1,546,200 | |
| $30.35 | +0.84 | +2.8% | $30.44 | $31.28 | $30.04 | 1,816,200 | |
| $29.51 | -0.05 | -0.2% | $29.23 | $29.86 | $28.94 | 896,400 | |
| $29.56 | +0.08 | +0.3% | $29.32 | $30.05 | $28.92 | 2,174,600 | |
| $29.48 | +0.62 | +2.1% | $28.55 | $29.68 | $27.97 | 1,151,100 | |
| $28.86 | -0.10 | -0.3% | $29.13 | $29.30 | $28.62 | 984,900 | |
| $28.96 | +0.22 | +0.8% | $28.87 | $29.25 | $28.67 | 943,900 | |
| $28.74 | +0.02 | +0.1% | $28.82 | $29.35 | $27.95 | 766,891 | |
| $28.72 | +0.10 | +0.3% | $28.38 | $29.03 | $28.38 | 912,850 | |
| $28.62 | +0.29 | +1.0% | $28.98 | $29.12 | $28.01 | 1,061,500 | |
| $28.33 | +0.63 | +2.3% | $29.40 | $29.43 | $27.29 | 2,696,600 | |
| $27.70 | -1.10 | -3.8% | $28.89 | $29.44 | $27.70 | 1,043,800 | |
| $28.80 | +1.18 | +4.3% | $28.21 | $28.87 | $27.98 | 845,209 | |
| $27.62 | -0.57 | -2.0% | $27.76 | $28.15 | $27.02 | 855,938 |
- Ticker
- BOATS:RCUS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Arcus Biosciences Announces New Employment Inducement Grants
Latest earnings call · Aug 5, 2026
Arcus Biosciences (NYSE:RCUS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 20, 2026
Investor Day (October 2026)
Investor day · 91 slides
Calls
Replays
Arcus Biosciences (NYSE:RCUS) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptArcus Biosciences (NYSE:RCUS) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch TranscriptArcus Biosciences (NYSE:RCUS) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Arcus Biosciences Announces New Employment Inducement Grants
Oct 26, 2026
Closed $18.14 (+2.1%) on Oct 27, 2026
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
Oct 21, 2026
Closed $19.36 (+1.4%) on Oct 22, 2026
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
Oct 21, 2026
Closed $19.36 (+1.4%) on Oct 22, 2026
Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer
Oct 20, 2026
Closed $23.75 (+7.3%) on Oct 20, 2026
Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy
Sep 22, 2026
Closed $26.87 (+3.5%) on Sep 22, 2026
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
Aug 5, 2026
Closed $28.33 (+2.3%) on Aug 6, 2026
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
Jul 22, 2026
Closed $29.73 (-0.8%) on Jul 23, 2026
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
Jul 22, 2026
Closed $29.73 (-0.8%) on Jul 23, 2026
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
Jul 21, 2026
Closed $29.97 (+1.7%) on Jul 22, 2026
Financings
Public offering of common stock
Oct 22, 2026
Update: US$250M · US$17.5 a share · Jefferies +4
Dealers: Jefferies (co-lead), Leerink Partners (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead), Mizuho (co-lead)
Decks
Investor Day (October 2026)
Investor day · 91 slides · Oct 20, 2026
Q2 2026 Earnings Presentation
Earnings · 42 slides · Aug 5, 2026
Goldman Sachs 47th Annual Global Healthcare Conference (June 2026)
Conference · 40 slides · Jun 9, 2026
Q1 2026 Earnings Presentation
Earnings · 40 slides · May 5, 2026
Arcus Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 41 in all · newest Oct 26, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 5, 2026
- Decks
- 18 decks · latest Oct 20, 2026
Where Arcus Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:RCUS · Home listing | NYSE | United States | USD |
| BOATS:RCUS · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Arcus Biosciences, Inc.